WEDNESDAY, Aug. 2, 2023 (HealthDay News) — Being exposed to lead while in the womb or during early childhood may increase a person’s chance of engaging in criminal behavior as an adult, a new review claims. To arrive at this conclusion, the review authors evaluated 17 previous studies that usedContinue Reading

TUESDAY, Aug. 1, 2023 (HealthDay News) — A micronutrient in human breast milk may provide significant benefit to developing newborn brains, according to new research that sheds light on the link between nutrition and brain health. Scientists looked at this sugar molecule in rodents and in human neurons. They saidContinue Reading

THURSDAY, July 20, 2023 (HealthDay News) — Every week, a group of dancers meets in Chicago. Together, they follow a series of movements under the guidance of an instructor. They flex, and reach, and point as Carly Liegel, community engagement program coordinator for the Joffrey Ballet, leads them through aContinue Reading

MONDAY, July 17, 2023 (HealthDay News) — Writing letters, taking classes and playing mentally stimulating games like chess in your older years could lower your risk of dementia over the next decade, a new study suggests. Researchers in Australia found that journaling, using a computer, taking education classes and otherContinue Reading

FRIDAY, July 14, 2023 (HealthDay News) — Ticks may be responsible for the spread of chronic wasting disease (CWD) in Wisconsin’s deer population, according to a new study. Researchers at the University of Wisconsin-Madison have found that ticks can harbor transmissible amounts of the protein particle that causes CWD, aContinue Reading

TUESDAY, July 11, 2023 (HealthDay News) — Children with autism have well-known difficulties with social interactions, but a new study is highlighting another area where they can struggle: memory. Researchers found that compared with their peers, school-age kids with autism showed more difficulty managing memory tasks. They often had aContinue Reading

THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading